SCHEMBL186734

SCHEMBL186734

O=CCc1ccc(Nc2c(F)cccc2C(F)(F)F)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.41
JAK1 P23458 2/20 0.38
JAK3 P52333 2/20 0.38
JAK2 O60674 2/20 0.36
EPHX2 P34913 1/20 0.35
MEN1 O00255 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
KMT2A Q03164 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SLC22A12 Q96S37 3/20 0.33
KCNQ3 O43525 2/20 0.33
KCNQ2 O43526 2/20 0.33
KCNE1 P15382 2/20 0.33
KCNQ1 P51787 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185826 0.84 PTGS2 (0.41) PTGS2JAK1JAK3JAK2EPHX2
SCHEMBL14957673 0.81 ALDH1A1 (0.41) EPHX2MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL27870381 0.79 PTGS2 (0.38) PTGS2JAK1JAK3JAK2EPHX2
SCHEMBL14957374 0.77 CNR2 (0.36) MEN1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL27870364 0.76 PTGS2 (0.37) PTGS2JAK1JAK3JAK2EPHX2
SCHEMBL2784614 0.75 JAK1 (0.43) PTGS2JAK1JAK3JAK2EPHX2
SCHEMBL246040 0.74 PTGS2 (0.41) PTGS2JAK1JAK3JAK2TYK2
SCHEMBL2806973 0.74 PTGS2 (0.44) PTGS2JAK1JAK3JAK2EPHX2
SCHEMBL186039 0.73 CHEK1 (0.50) CHEK1
SCHEMBL185856 0.72 RAB9A (0.40) MEN1CYP1A2CYP2D6CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed